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Mononuclear  cells  have  been  implicated  in the  primary  inﬂammatory  response  against  mycobacteria.
Yet,  little  is  known  about  the  interaction  of  Mycobacterium  bovis  bacillus  Calmette-Guerin  (BCG)  with
human  monocytes.  Here,  we  investigated  the potential  of  BCG  Moreau  strain  to induce  in  vitro speciﬁc
cell-death  utilizing  a ﬂow  cytometry  approach  that  revealed  an  increase  in apoptosis  events  in BCG-
stimulated  monocytes  from  healthy  adults.  We  also  detected  a concomitant  release  of interleukin  1
beta  (IL-1)  and  tumor  necrosis  factor  alpha  (TNF-),  but not  metalloproteinase  (MMP)-9.  In  addition,CG vaccine
uberculosis, Monocyte
poptosis,  Cytokine
annexin  V-propidium  iodide  double  staining  demonstrated  an  enhancement  of  monocytes  necrosis,  but
not  apoptosis,  following  BCG  Moreau  strain  stimulation  of  umbilical  vein  cells  from  naïve,  neonate.  This
pattern  was  paralleled  by  different  pro-inﬂammatory  cytokine  levels,  as  well  as MMP-9  induction  when
compared  to  the  adults.  Our  ﬁndings  support  the  hypothesis  that  BCG  induces  distinct  cell-death  patterns
during  the maturation  of  the  immune  system  and  that  this  pattern  might  set the  stage  for  a subsequent
e  resantimycobacterial  immun
. Introduction
In the early 90s, the World Health Organization selected tuber-
ulosis (TB) as a public health priority because it is the second
eading cause of death worldwide among infectious diseases. TB
s mostly concentrated in the developing world, with roughly 80%
f all TB cases occurring in the 22 highest-burden countries, includ-
ng Brazil. Although the worldwide TB incidence has decreased
t a rate of less than 1% per year in many settings over the past
ecade, case numbers and overall burden continue to rise in a
umber of countries, as a result of the rapid growth of the world
opulation [1]. This is directly associated with poor treatment out-
omes resulting in multidrug-resistance strains [2]. Despite the
mmunological parameters associated with pathogenesis of the dis-
ase being extensively studied, we still do not fully understand
he signaling mechanisms, transcriptional responses, sub-cellular
rocesses, and cell–cell interactions that follow Mycobacterium
uberculosis infection, particularly in the monocyte lineage. The cur-
ently vaccine in use is M.  bovis bacillus Calmette-Guerin (BCG)
hich results in a strong cellular immune response against M.
uberculosis, although protection is highly variable [3]. Thus, BCG
accine, despite being cheap and protective against severe forms
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of TB, it is not effective against pulmonary TB in hyper-endemic
countries [4]. The BCG strain currently used in Brazil is Moreau
(RDJ), but very little is known about its long-established protec-
tive properties. In vivo, the BCG Moreau strain induces a good DTH
skin test response and rarely causes local or systemic adverse reac-
tions. There is a lack of in vitro studies to understand the basis
of the protection induced by this stain. As the TB epidemic con-
tinues, more attention has been paid for direct applicability and
improvement of existing strategies of vaccination and manage-
ment.
Based on the limited data available and because
macrophage/monocyte lineage in the lungs represent the ﬁrst line
of defense to be recruited into the developing granuloma against
pathogens entering by the airways, the aim of this study focused
on understanding the pathways related to in vitro cell-death
pattern associated with the immune response to the BCG Moreau
strain in human monocytes. Previous studies have shown that
host cell apoptosis is an important defense mechanism against
mycobacteria [5,Reviewed by 6]. Soluble factors released dur-
ing BCG and monocyte interaction were also compared, since
TNF- has been shown to induce metalloproteinase (MMP)-9
expression, which, in turn, degrades extracellular matrix in
the inﬂammatory responses [7]. A better understanding of the
changes induced by BCG infection could help to identify the
Open access under the Elsevier OA license.processes resulting in protection, thus opening up prospects
for future vaccine improvement. Furthermore, this work should
result in better overall understanding of the pathogenesis of
tuberculosis.























































Fig. 1. Flow cytometry double staining demonstrates typical proﬁle from one rep-
resentative experiment. Healthy donor’s peripheral blood MC  stimulated with BCG
Moreau strain for 24 h was  used to set the gates for viable (lower left), apoptotic
(lower  right), and necrotic cells (upper right). Negligible dyes incorporation was
seen in the viable, live cells. As denoted in the dot plot, the percentages of cells areC.J.A. Simas et al. / Vac
. Patients and methods
.1.  Study participants
Two  groups of donors that may  represent a distinct cellular
mmune response resulting from a previous exposure to mycobac-
erial antigens were enrolled from different settings of Rio de
aneiro: Healthy donor adults (HD; n = 18) vaccinated with BCG dur-
ng childhood (BCG vaccination in Brazil is mandatory after birth)
rom the blood bank of Clementino Fraga Filho Federal University
ospital (anonymous donation policy, but included individuals age
18-years old), and newborn umbilical veins (UV; n = 8) of naïve
ndividuals (3 boys) who have never been exposed to mycobacteria
btained by ex utero umbilical cord blood puncture of non-smoker,
isease free mothers (all cesarean section at full terms: 37–42
eeks) from the Gaffree Guinle State University Hospital. The ex
tero umbilical cord blood collection procedures were as follows:
ost baby delivery, the placenta and cord were placed into a sterile
asin, 30 mL  of blood was regularly taken from the umbilical cord,
mmediately transferred to heparinized tubes and maintained at
oom temperature before processing. Exclusion criteria for those
ndividuals utilized HIV-seronegative status, a negative history of
alignant, degenerative, or transmitted diseases, diabetes melli-
us, and use of corticosteroids or other immunosuppressive agents
t the time of the study. In addition, the UV group also excluded
etal distress, mothers with a history of TB and any other maternal
nfection. This study was approved by the respective Institutional
eview Boards of both sites. All study participants provided written
nformed consent forms.
.2.  Mononuclear cells puriﬁcation and culture
Both Peripheral and Cord Blood Mononuclear Cells (MC) were
eparated (>92% purity) within 24 h of obtaining the blood spec-
mens from all study participants using a Ficoll density gradient.
he collected cells were ﬁrst washed 3-fold with endotoxin-free
hosphate buffered saline (PBS 50 mM,  pH 7.2), then suspended
n DMEM medium (Sigma Immunochemicals, MD,  USA) supple-
ented with 20% autologous serum. Cell cultures (1 × 106) were
ept at 37 ◦C in a humidiﬁed 5% CO2 atmosphere in individual
2 mm × 75 mm sterile polystyrene tubes (Falcon, Corning Inc., NY,
SA). Previous experiments with these tubes showed a better via-
ility of cells when compared to conventional culture plates (data
ot shown). Cells were used for subsequent cell death analysis, and
he supernatants were stored at −70 ◦C.
.3. In vitro MC  infection with BCG Moreau strain
The BCG Moreau (RDJ) strain used through was  a gift of the
taulpho de Paiva Foundation (Rio de Janeiro, Brazil). Individual
atches of sealed, single dose glass vials containing lyophilized BCG
approximately 1 × 107 viable bacilli) were maintained at 2–8 ◦C.
he same batch was used for each infection. Upon receipt, ampoules
ere suspended in water (provided separately by the manufac-
urer) shortly before the infection of cells. The effectiveness of BCG
oreau infection was previously determined using a titration curve
n order to establish the multiplicity of infection (MOI) ratio that
ould be used through the entire study, and accordingly the MOI
f 2:1 (bacilli:mononuclear cell ratio) was chosen. The viability
f the bacilli was promptly assessed by immunoﬂuorescence kits
LIVE/DEAD® BacLight, Invitrogen Co., USA)..4. Cell death assay by ﬂuorescence activating cell sorting (FACS)
MC from each donor were left in culture for 24 and 48 h. Tubes
ssigned as negative controls remained uninfected for the sameindicated in each quadrant. The monocyte population was  previously gated on the
basis of their light scattering properties. FL-1 and FL-3 represent annexin-V-FITC
and  propidium iodide stainings, respectively.
period. Positive control cells were subjected to heating just before
staining in order to force cell necrosis. After incubation, cells were
labeled with TACS kits as speciﬁed by the manufacturer (TACS, R&D,
USA) and immediately analyzed by ﬂow cytometry (FACScalibur,
BD, USA).
2.5. Detection of metaloproteinases (MMP) using zymography
and  ELISA
The MMP  activity in cell culture supernatants was analyzed
using substrate gel sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS–PAGE) zymography. After titration and lin-
earization at a maximum of 15 g of total protein, the samples
loaded in each slot were resolved in 10% polyacrylamide gels
containing 1% of gelatin per mL  at 100 V for about 3 h. The gels
were then incubated for 1 h on a rotating platform in TBS (10 mM
Tris–HCl, 0.15 M NaCl, pH 7.6) containing 2.5% Triton X-100. Gels
were washed three times in TBS and then incubated for 24 h at
37 ◦C in TBS containing 5 mM CaCl2, 1% Triton X-100, and 0.02%
NaN3. Coomassie blue staining revealed the presence of gelati-
nolytic activity as clear bands against the blue background. Cell-free
supernatants were also assayed for total (active and pro) MMP-9
quantiﬁcation by an enzyme-linked immunosorbent assay (ELISA)
human commercial kit as speciﬁed by the manufacturer (R&D Sys-
tems, USA).
2.6.  Cytokine detection
Cell-free  supernatants were thawed out and subsequently
assayed for determination of the concentration of human TNF-
and IL-1 by ELISA commercial kits as speciﬁed by the manufac-
turer (R&D Systems, USA).
2.7.  Statistical evaluationData  were analyzed by GraphPad Instat software, using the
student t test to compare both groups of individuals. MMP-9 pro-
duction was represented as the mean ± standard error of mean
6448 C.J.A. Simas et al. / Vaccine 29 (2011) 6446– 6450
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eig. 2. In-gel gelatin zymography was performed on samples from healthy donor a
oreau strain (lanes 3, 5, 7 and 9). A recombinant human MMP-9 was loaded (lane
n each group) correspond to the characteristic 72-kDa MMP-2 and 92-kDa MMP-9




We  have enrolled two groups of donors for this particular study:
 group of healthy donor adults (HD), and another group of naïve
ndividuals using umbilical vein (UV) cells promptly collected after
irth. Cells were infected with BCG Moreau for 24 and 48 h (after
econstitution, yielding an average of 87% of live bacilli), or were
esting (baseline) uninfected cells with no stimuli. After lympho-
yte population exclusion based on light scattering properties,
ell-death events were analyzed using annexin-V and propidium
odide, which detect apoptosis (single positive) and necrosis (dou-
le positive; Fig. 1). Table 1 summarizes those ﬁndings (some
ndividuals were excluded). After BCG Moreau infection at both
ime-points, we observed a signiﬁcant increase in apoptotic events
nly in the HD group (p ≤ 0.001). On the other hand, UV cells
howed a signiﬁcant increase of necrotic events at 24 h of infec-
ion, when compared to negative control (p ≤ 0.006). As expected,
he positive control cells (heating samples was used to artiﬁcially
nduce necrosis) showed increased necrotic events in both groups,
nd similar differences were found when the 2 distinct cell-death
atterns were compared (Table 1).
.2. Detection of metaloproteinases (MMP)  using zymography
nd  ELISA
Fig.  2 shows a representative gelatin zymography of the 2
ohorts studied. In the typical pattern, a middle, thick band
ontained active MMP-9 (92 kDa), and the weak, bottom band con-
ained the pro-active MMP-2 (72 kDa). We  did not observe the
MP-2 fully-active bands. The HD group did not show any sig-
iﬁcant change during the course of BCG infection (24 h), when
ompared the baseline cells. A similar pattern was  seen in the
V group, although with a much lower intensity and there was
o change in the MMP-2 and MMP-9 bands when compared to
aseline cells (Fig. 2).
In addition, we evaluated the in vitro total MMP-9 levels in
he 2 groups using ELISA. After BCG infection, there was  no differ-
nce in induced levels of MMP-9 in either cohort. In the UV group,bilical vein groups in baseline (lanes 2, 4, 6 and 8) and 24-h of infection with BCG,
 represent the active enzyme. Bands shown in the gel (representative of 2 patients
= molecular weight.
BCG-induced  MMP-9 levels remained undetectable (0.6 ± 0.1 and
0.5 ± 0.2 g/mL, for 24 and 48 h, respectively) which is similar
to baseline levels (0.6 ± 0.2 g/mL). However, the HD group did
show much higher productions when compared to the UV group
(p ≤ 0.002), regardless of the stimuli, i.e.: BCG infection (13.0 ± 2.6,
12.8 ± 1.0 and 9.9 ± 1.3 g/mL, for baseline, 24 and 48 h, respec-
tively). This data mirrored the zymographic analysis results.
3.3.  Cytokine detection
It  was shown earlier that pro-inﬂammatory cytokines, such as
TNF- and IL-1, play a key role during in vitro apoptosis induction
[5,8], particularly when monocytes are infected with mycobacteria
[9]. We  therefore assayed the supernates from groups undergoing
enhanced apoptosis for those 2 cytokines (some individuals were
excluded), and a proportional increase of TNF- levels was  evident
only for the HD group (Fig. 3a; p < 0.004). However, this ﬁnding did
not mirror that of the UV group since the rates of TNF- remained
undetectable even in the presence of BCG infection at both time-
points. Also, there was a statistically signiﬁcant difference at 24 h
of infection when HD and UV groups were compared (p = 0.03). The
pro-inﬂammatory cytokine IL-1, for which cell-death induction is
also one of its main functions [8], was  also assayed. There was  a
marked increase in IL-1 levels that were directly proportional to
the time of BCG infection in the HD group (Fig. 3b; p ≤ 0.02). This
pattern was also a trend in the UV group, but opposite to TNF-,
although it did not attain a statistically signiﬁcant difference when
compared to the baseline condition. Also, no discrepancy was found
when evaluating the IL-1 levels between the 2 cohorts in this last,
resting condition (p = 0.85).
4.  Discussion
It has been previously shown that mycobacteria are able to
induce macrophage apoptosis, and the inhibition of this criti-
cal mechanism might be considered an evasive strategy of the
pathogen [Reviewed by 6]. Evasion of apoptosis by M. tuberculo-
sis can be achieved in human macrophages by enhanced release
of sTNFR2 [6], Mcl-1 [10], bcl-2 and Rb [11], and lower produc-
tions of prostaglandin E2 [12], bad and bax, and caspases-1, -3
and -10 [11]. On the other hand, necrosis can be looked at as a
good strategy induced by pathogenic mycobacteria to skew the
protective host immune response. Since 2005, a novel form of
C.J.A. Simas et al. / Vaccine 29 (2011) 6446– 6450 6449
Table 1
Average (mean ± SEM) of speciﬁc cell-death (%) in monocytes of healthy donor (HD, n = 16) and umbilical vein (UV, n = 5) groups.
Apoptosis Necrosis
HD UV HD UV
Negative control 7.9 ± 1.3 9.7 ± 3.1 7.0 ± 1.3 6.7 ± 2.1
BCG  24 h 32.7 ± 6.4a,b 19.6 ± 4.9 9.1 ± 1.7 28.0 ± 5.4a
BCG 48 h 29.5 ± 4.9a,b nd 11.0 ± 1.6 nd
Positive  controlc 21.3 ±  5.6 9.5 ± 2.3 58.5 ± 6.8a,b 73.8 ± 10.9a,b










cb p ≤ 0.002, when compared to distinct cell-death pattern.
c Heating samples was  used to artiﬁcially induce necrosis.
roinﬂammatory programmed cell death, or pyroptosis, has been
dentiﬁed to be uniquely dependent on caspase-1, which is not
nvolved in apoptosis, and prototypically induced by infection
ith ﬂagellin-expressing bacteria, such as Salmonella and Shigella
pecies [13]. To date, pyroptosis seems to play a signiﬁcant role
n speciﬁc biological systems. It has been previously shown that
ig. 3. (a) TNF- and  (b) IL-1 levels (pg/mL) in healthy donor () and umbilical
ein () groups representing different times of in vitro BCG Moreau strain infec-
ion  in human monocytes. Horizontal bars represent mean cytokine values in each
ondition. *p < 0.004, **p ≤ 0.02 vs. Ctl.this mechanism releases bacteria from macrophages and exposes
the bacteria to uptake and killing by reactive oxygen species in
neutrophils [14]. Similarly, activation of caspase-1 cleared intracel-
lular Legionella pneumophila and Burkholderia thailandensis in vivo
by IL-1-independent mechanisms, an efﬁcient bactericidal mech-
anism by the innate immune system [14]. In this study, we did
not check whether pyroptotic cell death takes place in our sys-
tem; however, based on the latest notion highlighted by those
authors, the increased IL-1 levels found in the cultures could
not support this possibility. With this in mind, and regarding M.
bovis BCG as a low virulent organism, we  can hypothesize high in
vitro apoptosis levels when healthy donor monocytes are infected
in a short-time manner. Actually, this is true only in previously
exposed, adult individuals in which a BCG vaccination scar was
present along with a history of living in a setting of environmen-
tal mycobacteria, such as Brazil. We  were not, however, able to
reproduce those ﬁndings in monocytes from naïve individuals;
rather, necrosis was quite evident, particularly at 24 h of infec-
tion. The reasons behind this are speculative; perhaps this is due
to a higher amount of circulating immature immune cells or to
a lack of exposure to mycobacterial antigens. In fact, because of
decreased production of Th1-cell-associated cytokines, it is thought
that the neonatal innate immune system is generally impaired or
depressed. The bias against Th1-cell-polarizing cytokines leaves
the newborn susceptible to microbial infection and contributes to
impairment of the neonatal immune responses to most vaccines,
thereby frustrating efforts to protect this vulnerable population
[15]. The ability of pro-inﬂammatory cytokines to induce sponta-
neous abortion is likely to be an important reason for the strong bias
of the maternal and fetal immune systems of many mammalian
species towards Th2-cell-polarizing cytokines [Reviewed by 16].
After birth, there is an age-dependent maturation of the immune
response. Thus, the higher necrosis levels in these subjects might
reﬂect still very immature monocytes in which BCG could behave
as a moderate virulence organism. In fact, in immune compromised
individuals, such as those co-infected with HIV, BCG is considered a
life-threaten organism due to impairment of the immune response
[17].
In an attempt to better explore the apoptosis and necrosis ﬁnd-
ings, we  also measured levels of pro-inﬂammatory cytokines, the
key components during cell-death induction. TNF- is a pleiotropic
cytokine during Th1 immune responses and it is also closely con-
nected to mechanism of cell death, given this cytokine is intrinsic
ability to activate caspases and thus induce apoptosis [Reviewed by
18]. This topic was considered in a previous study, where M.  avium-
induced macrophage apoptosis was  dependent on the function of
TNF- because it was inhibited by the presence of anti-TNF- anti-
bodies [5]. In fact, true TNF- bioactivity was  actually reduced
in supernatants from M.  tuberculosis-infected cell cultures due to
neutralization when soluble TNFR2, but not TNFR1, was  released
during macrophage infection [Reviewed by 6]. Accordingly, we
observed a signiﬁcant and progressive increase in the levels of
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D individuals that was consistent with the increased rate of apo-
tosis in this group. This phenomenon was also supported by the
act that the apoptosis levels were not dominant in the imma-
ure, naïve group. There, TNF- level is unchanged, while IL-1
ends to increase over the time during BCG infection. It is note-
orthy that at 24 h of infection, both groups produced comparable
L-1 levels (HD = 757.7 ± 258 pg/mL vs. UV = 676.8 ± 124 pg/mL;
 = n.s.).
There are both quantitative and qualitative differences between
onocytes from newborns and adults. Qualitative differences are
vident in utero, as human fetal circulating monocytes reveal
educed levels of MHC  class II molecules. Also, the addition of
ndotoxin to whole cord blood from human newborns results in
iminished production of TNF when compared with adult periph-
ral blood [19]. Indeed, newborn-derived monocytes cultured in
hole blood or puriﬁed and cultured in autologous, newborn blood
lasma show a 1-3-log impairment in TNF production in response
o agonists of toll-like receptors [Reviewed by 16]. Thus, it has been
onﬁrmed that cells from umbilical cord produce fewer cytokines,
uch TNF-, when compared to adult cells [19]. Another pattern
as found when studying MMP-9 levels induced by BCG-infected
onocytes. MMP-9 is a metalloproteinase with pro-inﬂammatory
roperties and some speciﬁc functions, such as a reducing response
o IL-2, generating similar fragments of angiostatin, having a high
fﬁnity for collagen, and stimulating secretion of cytokines, among
hem TNF- and IL-1 [20]. Strikingly, virtually no production
as found only in the naïve group, but again BCG was not able
o distinguish resting, baseline levels found in the HD group. This
bservation can also be explained by circulating immature cells
f the naïve group, as opposed to the already sensitized adults, to
romptly produce MMP-9. As expected, this pattern was  in agree-
ent with the in-gel gelatin data, although those techniques are
ot related, and thus, the results are not directly compared because
hey have distinct sensitivities. On the other hand, Quiding-Jarbrink
nd colleagues in 2001 [20] showed increasing rates of MMP-9, but
his may  be related to different MOI  ratio between theirs and the
resent study (10:1 vs. 2:1 respectively).
In summary, one could conclude that the necrosis pattern found
n monocytes from naïve group correlates well with IL-1 levels,
ut not with TNF- and MMP-9, induced when those cells are BCG
nfected. Additional studies are warranted to rule out other mech-
nisms, such as pyroptosis. These ﬁndings support the hypothesis
hat BCG Moreau strain induces distinct cell-death patterns involv-
ng maturation of the immune system and that this pattern might
et the stage for a subsequent antimycobacterial immune response,
hich may  have profound effects during vaccination.
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